GHDX News and Press, Genomic Health Inc. From 07/30/19

Cellectar Biosciences (NASDAQ: CLRB ) initiated with Buy rating and $6 (180% upside) price target at Brookline Capital. Shares up  8%  premarket. More news on: Cellectar Biosciences, Inc., Heat Biologics, Inc., Progenics Pharmaceuticals, Inc., Healthcare stocks news, Stocks on th...

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Genomic Health, Inc. (NASDAQ: GHDX) to Exact Sciences Corp. is fair to Genomic Health shareholders. On behalf of Genomic Health shareholders, Halper Sad...

Exact Sciences (NASDAQ: EXAS ) and Genomic Health (NASDAQ: GHDX ) have agreed to merge in a cash-and-stock transaction valued at $2.8B ($72/GHDX common share). The deal should close by year-end. More news on: Exact Sciences Corporation, Genomic Health, Inc., Healthcare stocks news, Stock...

Genomic Health (NASDAQ: GHDX ): Q2 GAAP EPS of $0.42 beats by $0.07 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Negotiators for the U.S. and China are facing off in Shanghai this week in another attempt to piece ...

REDWOOD CITY, Calif. , July 29, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended June 30 , 2019.  The company's earnings call and webcast previously scheduled for Thursday, August 1 ...

MADISON, Wis. and REDWOOD CITY, Calif. , July 29, 2019 /PRNewswire/ --   Exact Sciences Corp. (NASDAQ: EXAS) and Genomic Health, Inc. (NASDAQ: GHDX) today announced that the companies have entered into a definitive agreement under which Exact Sciences will combine with Genomic...

Bloomberg reports that Exact Sciences (NASDAQ: EXAS ) is in advanced talks to acquire Genomic Health (NASDAQ: GHDX ) for $2.8B. A deal could be announced as early as next week. More news on: Exact Sciences Corporation, Genomic Health, Inc., Healthcare stocks news, Merger & acquisitio...

REDWOOD CITY, Calif. , July 25, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Thursday, August 1 at 4:30 p.m. Eastern Time to discuss its second quarter 2019 financial results. T...

Gainers:  DelMar Pharmaceuticals (NASDAQ: DMPI ) +39%.  SigmaTron International (NASDAQ: SGMA ) +22% . Nuvectra Corporation (NASDAQ: NVTR ) +20% . Teradyne (NASDAQ: TER ) +18% . Manhattan Associates (NASDAQ: MANH ) +18% . Snap (NYSE: SNAP ) +16% . Acasti Pharma (NASDAQ: ACS...